Literature DB >> 14444477

Thrombin-E as a fibrinolytic enzyme.

W H SEEGERS, R H LANDABURU, J F JOHNSON.   

Abstract

Thrombin-E has been produced in adequate quantity for pharmacological studies. After intravenous infusion in dogs there were no significantchanges in blood pressure, temperature, pulse rate, and respiratory movements. There were drops in platelet and white cell count, and there was an increase in bloodsugar level. Powerful fibrinolytic phenomena wereobserved.

Entities:  

Keywords:  THROMBIN

Mesh:

Substances:

Year:  1960        PMID: 14444477     DOI: 10.1126/science.131.3402.726

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  5 in total

1.  [Blood platelets and coagulationactive plasma proteins. A short summary of their function and pathology].

Authors:  E MAMMEN; R GROSS
Journal:  Blut       Date:  1962-05

2.  Isolation of thrombin-E and the evolution of enzyme activity from prothrombin.

Authors:  W H Seegers; L E McCoy; D A Walz; J Reuterby; T J Andary
Journal:  Experientia       Date:  1974-10-15

3.  Increased plasminogen activator (urokinase) in tissue culture after fibrin deposition.

Authors:  M B Bernik
Journal:  J Clin Invest       Date:  1973-04       Impact factor: 14.808

4.  [Fibrinolytic acitivity of thrombin].

Authors:  D Voss
Journal:  Klin Wochenschr       Date:  1965-09-01

5.  [On the demonstration and occurrence and the importance of the intracorporeal origin of fibrinogen breakdown products with special consideration of the demonstration of high molecular fibrin breakdown products in menstrual blood].

Authors:  R Marx; W Weinzierl; G Schwick; K Störiko
Journal:  Blut       Date:  1965-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.